<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36749589</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US.</ArticleTitle><Pagination><StartPage>e2254909</StartPage><MedlinePgn>e2254909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2254909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.54909</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Rhinoviruses and/or enteroviruses, which continued to circulate during the COVID-19 pandemic, are commonly detected in pediatric patients with acute respiratory illness (ARI). Yet detailed characterization of rhinovirus and/or enterovirus detection over time is limited, especially by age group and health care setting.</AbstractText><AbstractText Label="OBJECTIVE">To quantify and characterize rhinovirus and/or enterovirus detection before and during the COVID-19 pandemic among children and adolescents seeking medical care for ARI at emergency departments (EDs) or hospitals.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cross-sectional study used data from the New Vaccine Surveillance Network (NVSN), a multicenter, active, prospective surveillance platform, for pediatric patients who sought medical care for fever and/or respiratory symptoms at 7 EDs or hospitals within NVSN across the US between December 2016 and February 2021. Persons younger than 18 years were enrolled in NVSN, and respiratory specimens were collected and tested for multiple viruses.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Proportion of patients in whom rhinovirus and/or enterovirus, or another virus, was detected by calendar month and by prepandemic (December 1, 2016, to March 11, 2020) or pandemic (March 12, 2020, to February 28, 2021) periods. Month-specific adjusted odds ratios (aORs) for rhinovirus and/or enterovirus-positive test results (among all tested) by setting (ED or inpatient) and age group (&lt;2, 2-4, or 5-17 years) were calculated, comparing each month during the pandemic to equivalent months of previous years.</AbstractText><AbstractText Label="RESULTS">Of the 38&#x202f;198 children and adolescents who were enrolled and tested, 11&#x202f;303 (29.6%; mean [SD] age, 2.8 [3.7] years; 6733 boys [59.6%]) had rhinovirus and/or enterovirus-positive test results. In prepandemic and pandemic periods, rhinoviruses and/or enteroviruses were detected in 29.4% (9795 of 33 317) and 30.9% (1508 of 4881) of all patients who were enrolled and tested and in 42.2% (9795 of 23 236) and 73.0% (1508 of 2066) of those with test positivity for any virus, respectively. Rhinoviruses and/or enteroviruses were the most frequently detected viruses in both periods and all age groups in the ED and inpatient setting. From April to September 2020 (pandemic period), rhinoviruses and/or enteroviruses were detectable at similar or lower odds than in prepandemic years, with aORs ranging from 0.08 (95% CI, 0.04-0.19) to 0.76 (95% CI, 0.55-1.05) in the ED and 0.04 (95% CI, 0.01-0.11) to 0.71 (95% CI, 0.47-1.07) in the inpatient setting. However, unlike some other viruses, rhinoviruses and/or enteroviruses soon returned to prepandemic levels and from October 2020 to February 2021 were detected at similar or higher odds than in prepandemic months in both settings, with aORs ranging from 1.47 (95% CI, 1.12-1.93) to 3.01 (95% CI, 2.30-3.94) in the ED and 1.36 (95% CI, 1.03-1.79) to 2.44 (95% CI, 1.78-3.34) in the inpatient setting, and in all age groups. Compared with prepandemic years, during the pandemic, rhinoviruses and/or enteroviruses were detected in patients who were slightly older, although most (74.5% [1124 of 1508]) were younger than 5 years.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Results of this study show that rhinoviruses and/or enteroviruses persisted and were the most common respiratory virus group detected across all pediatric age groups and in both ED and inpatient settings. Rhinoviruses and/or enteroviruses remain a leading factor in ARI health care burden, and active ARI surveillance in children and adolescents remains critical for defining the health care burden of respiratory viruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rankin</LastName><ForeName>Danielle A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spieker</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Ariana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Dynamics Information Technology Inc, Falls Church, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stahl</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Herdi K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Laura S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuster</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lively</LastName><ForeName>Joana Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddadin</LastName><ForeName>Zaid</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Probst</LastName><ForeName>Varvara</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaels</LastName><ForeName>Marian G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>John V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boom</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahni</LastName><ForeName>Leila C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staat</LastName><ForeName>Mary A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlaudecker</LastName><ForeName>Elizabeth P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeal</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinberg</LastName><ForeName>Geoffrey A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szilagyi</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, UCLA (University of California, Los Angeles) Mattel Children's Hospital, UCLA, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Seattle Children's Hospital, Department of Pediatrics, University of Washington School of Medicine, Seattle.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Eileen J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Seattle Children's Hospital, Department of Pediatrics, University of Washington School of Medicine, Seattle.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Susan I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMorrow</LastName><ForeName>Meredith</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chappell</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvarangan</LastName><ForeName>Rangaraj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, Kansas City, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Midgley</LastName><ForeName>Claire M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halasa</LastName><ForeName>Natasha B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NVSN Network Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 IP001054</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001150</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001158</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR002244</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001157</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 IP001049</GrantID><Acronym>IP</Acronym><Agency>NCIRD CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Spieker reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Schuster reported receiving grants for her institution from Merck &amp; Co, Inc outside the submitted work. Dr Williams reported receiving personal fees from Quidel and GlaxoSmithKline outside the submitted work. Dr Sahni reported receiving grants for her institution from the Centers for Disease Control and Prevention (CDC) outside the submitted work. Dr Staat reported receiving grants from the NIH outside the submitted work. Dr Schlaudecker reported receiving grants from Pfizer and personal fees from Sanofi Pasteur outside the submitted work. Dr Harrison reported receiving grants for his institution from Children's Mercy Hospital during the conduct of the study and grants from GlaxoSmithKline, Pfizer, Merck &amp; Co, Inc, and COVID-19 Prevention Network outside the submitted work. Dr Weinberg reported receiving personal fees from Merck &amp; Co, Inc outside the submitted work. Dr Szilagyi reported receiving grants from the University of California, Los Angeles David Geffen School of Medicine BROAD Program during the conduct of the study. Dr Englund reported receiving grants from GlaxoSmithKline and Pfizer as well as personal fees from Meissa Vaccines, Moderna, Pfizer, Sanofi Pasteur, AstraZeneca, and Novavax outside the submitted work. Dr Gerber reported being employed at the CDC during the conduct of the study and at GlaxoSmithKline outside the submitted work. Dr Chappell reported receiving grants from the NIH during the conduct of the study. Dr Selvarangan reported receiving grants from Merck &amp; Co, Inc, BioFire, Luminex, Hologic, Abbott, Becton Dickinson, and Cepheid outside the submitted work. Dr Halasa reported receiving grants from Sanofi and Quidel as well as personal fees from Genentech outside the submitted work. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Moffatt</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weddle</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strelitz</LastName><ForeName>Bonnie</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacombe</LastName><ForeName>Kristen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rohlfs</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36749589</ArticleId><ArticleId IdType="pmc">PMC10408278</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.54909</ArticleId><ArticleId IdType="pii">2801017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amaddeo A, Cason C, Cozzi G, Ronfani L, Comar M. Social distancing measures for COVID-19 are changing winter season. Arch Dis Child. 2021;106(12):e47. doi:10.1136/archdischild-2021-322004</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-322004</ArticleId><ArticleId IdType="pubmed">34031029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I, Artama M, Haapanen M, Renko M. Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-a nationwide register study in Finland. J Med Virol. 2021;93(10):6063-6067. doi:10.1002/jmv.27180</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27180</ArticleId><ArticleId IdType="pmc">PMC8426983</ArticleId><ArticleId IdType="pubmed">34228369</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott D, Beresford R, Mirdad F, et al. . Concomitant marked decline in prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent&#x2019;s Hospital and associated screening clinics, Sydney, NSW. Clin Infect Dis. 2021;72(10):e649-e651. doi:10.1093/cid/ciaa1256</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1256</ArticleId><ArticleId IdType="pmc">PMC7499558</ArticleId><ArticleId IdType="pubmed">32841316</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Michelow IC, Choe YJ. Shifting patterns of respiratory virus activity following social distancing measures for Coronavirus disease 2019 in South Korea. J Infect Dis. 2021;224(11):1900-1906. doi:10.1093/infdis/jiab231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab231</ArticleId><ArticleId IdType="pmc">PMC8135809</ArticleId><ArticleId IdType="pubmed">34009376</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole S, Brendish NJ, Tanner AR, Clark TW. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus. Lancet Respir Med. 2020;8(12):e92-e93. doi:10.1016/S2213-2600(20)30502-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30502-6</ArticleId><ArticleId IdType="pmc">PMC7581315</ArticleId><ArticleId IdType="pubmed">33289636</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlberger-Fritz M, Kundi M, Aberle SW, Puchhammer-St&#xf6;ckl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021;137:104795. doi:10.1016/j.jcv.2021.104795</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104795</ArticleId><ArticleId IdType="pmc">PMC7962988</ArticleId><ArticleId IdType="pubmed">33761423</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E, Kawakami C, Momoki T, et al. . Increased risk of rhinovirus infection in children during the Coronavirus disease-19 pandemic. Influenza Other Respir Viruses. 2021;15(4):488-494. doi:10.1111/irv.12854</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12854</ArticleId><ArticleId IdType="pmc">PMC8189209</ArticleId><ArticleId IdType="pubmed">33715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenholme A, Webb R, Lawrence S, et al. . COVID-19 and infant hospitalizations for seasonal respiratory virus infections, New Zealand, 2020. Emerg Infect Dis. 2021;27(2):641-643. doi:10.3201/eid2702.204041</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.204041</ArticleId><ArticleId IdType="pmc">PMC7853573</ArticleId><ArticleId IdType="pubmed">33263515</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh DY, Buda S, Biere B, et al. . Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: analysis of national surveillance data. Lancet Reg Health Eur. 2021;6:100112. doi:10.1016/j.lanepe.2021.100112</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100112</ArticleId><ArticleId IdType="pmc">PMC8183189</ArticleId><ArticleId IdType="pubmed">34124707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodjat P, Christensen PA, Subedi S, Bernard DW, Olsen RJ, Long SW. The reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions. Microbiol Spectr. 2021;9(2):e0043021. doi:10.1128/Spectrum.00430-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00430-21</ArticleId><ArticleId IdType="pmc">PMC8557899</ArticleId><ArticleId IdType="pubmed">34494861</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013-1019. doi:10.15585/mmwr.mm7029a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers L, Sheppard M, Smith A, et al. . Changes in seasonal respiratory illnesses in the United States during the Coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2021;73(suppl 1):S110-S117. doi:10.1093/cid/ciab311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab311</ArticleId><ArticleId IdType="pmc">PMC8135472</ArticleId><ArticleId IdType="pubmed">33912902</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, et al. . Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics. 2021;148(2):e2021051462. doi:10.1542/peds.2021-051462</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051462</ArticleId><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Perez A, Lively JY, et al. . Enterovirus D68-associated acute respiratory illness &#x2500; New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021;70(47):1623-1628. doi:10.15585/mmwr.mm7047a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7047a1</ArticleId><ArticleId IdType="pmc">PMC8612514</ArticleId><ArticleId IdType="pubmed">34818320</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell AP, Ogokeh C, Lively JY, et al. . Vaccine effectiveness against pediatric influenza hospitalizations and emergency visits. Pediatrics. 2020;146(5):e20201368. doi:10.1542/peds.2020-1368</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-1368</ArticleId><ArticleId IdType="pubmed">33020249</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha B, Curns AT, Lively JY, et al. . Respiratory syncytial virus-associated hospitalizations among young children: 2015-2016. Pediatrics. 2020;146(1):e20193611. doi:10.1542/peds.2019-3611</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2019-3611</ArticleId><ArticleId IdType="pubmed">32546583</ArticleId></ArticleIdList></Reference><Reference><Citation>Code of Federal Regulations. A point in time eCFR system. Title 45. February 22, 2022. Accessed May 2022. https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&amp;mc=true&amp;node=pt45.1.46&amp;rgn=div5#se45.1.46_1102
</Citation></Reference><Reference><Citation>Rha B, Lively JY, Englund JA, et al. . Severe acute respiratory syndrome coronavirus 2 infections in children: multicenter surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020;9(5):609-612. doi:10.1093/jpids/piaa075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa075</ArticleId><ArticleId IdType="pmc">PMC7337823</ArticleId><ArticleId IdType="pubmed">32556327</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases . National Respiratory and Enteric Virus Surveillance System (NREVSS). Accessed January 2022. https://www.cdc.gov/surveillance/nrevss/index.html
</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention Health Alert Network. Increased interseasonal respiratory syncytial virus (RSV) activity in parts of the Southern United States. Accessed January 2022. https://emergency.cdc.gov/han/2021/han00443.asp
</Citation></Reference><Reference><Citation>Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? a systematic review. BMC Infect Dis. 2006;6:130. doi:10.1186/1471-2334-6-130</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-6-130</ArticleId><ArticleId IdType="pmc">PMC1564025</ArticleId><ArticleId IdType="pubmed">16914034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Q, Lim JYC, Xue K, et al. . Sanitizing agents for virus inactivation and disinfection. View (Beijing). 2020;1(2):e16. doi:10.1002/viw2.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/viw2.16</ArticleId><ArticleId IdType="pmc">PMC7267133</ArticleId><ArticleId IdType="pubmed">34766164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A, Assadian O. Survival of microorganisms on inanimate surfaces. In: Borkow G, ed. Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections. Cupron Inc; 2014:7-26. doi:10.1007/978-3-319-08057-4_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-08057-4_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Lu X, Erdman DD, et al. ; New Vaccine Surveillance Network . Rhinovirus-associated hospitalizations in young children. J Infect Dis. 2007;195(6):773-781. doi:10.1086/511821</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/511821</ArticleId><ArticleId IdType="pmc">PMC7109786</ArticleId><ArticleId IdType="pubmed">17299706</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A, Lively JY, Curns A, et al. ; New Vaccine Surveillance Network Collaborators . Respiratory virus surveillance among children with acute respiratory illnesses: New Vaccine Surveillance Network, United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2022;71(40):1253-1259. doi:10.15585/mmwr.mm7140a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7140a1</ArticleId><ArticleId IdType="pmc">PMC9541034</ArticleId><ArticleId IdType="pubmed">36201373</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Hingrat Q, Bouzid D, Choquet C, et al. . Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses. 2021;15(4):425-428. doi:10.1111/irv.12853</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12853</ArticleId><ArticleId IdType="pmc">PMC8189235</ArticleId><ArticleId IdType="pubmed">33817971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu HY, Englund JA, Starita LM, et al. ; Seattle Flu Study Investigators . Early detection of COVID-19 through a citywide pandemic surveillance platform. N Engl J Med. 2020;383(2):185-187. doi:10.1056/NEJMc2008646</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008646</ArticleId><ArticleId IdType="pmc">PMC7206929</ArticleId><ArticleId IdType="pubmed">32356944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciacchini B, Tonioli F, Marciano C, et al. . Reluctance to seek pediatric care during the COVID-19 pandemic and the risks of delayed diagnosis. Ital J Pediatr. 2020;46(1):87. doi:10.1186/s13052-020-00849-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-020-00849-w</ArticleId><ArticleId IdType="pmc">PMC7322712</ArticleId><ArticleId IdType="pubmed">32600464</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Blozinski A, Fernandez K, et al. . Changes in pediatric emergency department visits during the COVID-19 pandemic. Hosp Pediatr. 2021;11(4):e57-e60. doi:10.1542/hpeds.2020-005074</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2020-005074</ArticleId><ArticleId IdType="pubmed">33436415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond C, Kurten M, Kennedy JL. Rhinovirus and asthma: a storied history of incompatibility. Curr Allergy Asthma Rep. 2015;15(2):502. doi:10.1007/s11882-014-0502-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-014-0502-0</ArticleId><ArticleId IdType="pmc">PMC4327812</ArticleId><ArticleId IdType="pubmed">25612798</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Edwards KM, Weinberg GA, et al. ; New Vaccine Surveillance Network . A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009;123(1):98-104.e1. doi:10.1016/j.jaci.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2008.10.007</ArticleId><ArticleId IdType="pmc">PMC7112283</ArticleId><ArticleId IdType="pubmed">19027147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>